Search

everythinglearnresearchcommunity

for

Search:↓

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Topical Saw Palmetto and Trichogen Veg Complex increased hair count by 11.9% and improved hair growth in 48% of men with hair loss.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Finasteride and minoxidil are the main effective treatments for hair loss from androgenetic alopecia.

Finasteride is effective in stopping hair loss and promoting regrowth in most men with mild side effects.

Finasteride effectively treats mild to moderate hair loss in men aged 18-41, with some side effects.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.

Finasteride reduces blood loss and the need for blood transfusions during and after TURP surgery.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Vitamin A toxicity likely caused the patient's high calcium levels.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

The technique accurately identifies and evaluates hair follicle structures in skin.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

For better medication adherence in benign prostatic hyperplasia treatment, tamsulosin and finasteride should be packaged together and taken at the same time.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.